OpSens Announces Closing of $28.75 M Bought Deal Public Offering Including $3.75 M Over-Allotment Option Exercised in Full THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR […]
Category: News & Events
OpSens Obtains CE Marking for the OptoWire III
OpSens Obtains CE Marking for the OptoWire III Quebec City, Quebec, February 18, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, has […]
OPSENS AWARDED CONTRACT BY MAJOR U.S. GROUP PURCHASING ORGANIZATION
OPSENS AWARDED CONTRACT BY MAJOR U.S. GROUP PURCHASING ORGANIZATION OptoWire gains access to more than 50 PCI centers Quebec City, Quebec, October 14, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company commercializing a second-generation fiber optic […]
OpSens to Present at Lytham Partners Virtual Investor Growth Conference
Quebec City, Quebec, September 30, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, will participate in a virtual presentation and fireside chat […]
OPSENS TO PRESENT AT THE LD 500 VIRTUAL CONFERENCE
OPSENS TO PRESENT AT THE LD 500 VIRTUAL CONFERENCE Quebec City, Quebec, August 26, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a Company focusing mainly on physiological measurements in interventional cardiology, today announced it will be presenting at the […]
OpSens Releases Q3 Results
OPSENS ANNOUNCES RESULT FOR Q3 2020 Quebec City, Quebec, July 15, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter of 2020. Highlights Net earnings of $0.1 M for the third […]
Opsens – 100,000 Cases Performed with the OptoWire
Opsens – 100,000 cases performed with the OptoWire Quebec City, Quebec, May 20, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) reached an important milestone with more than 100,000 patients evaluated with the OptoWire™, a pressure guidewire for the […]
The Financial Post: How is OpSens improving cardiovascular disease treatment?
The Financial Post released a piece based on this week’s interview on OpSens’ C-Suite at the Open, a series highlighting the stories of companies listed on the TSX. Link to Financial Post piece […]
OpSens at C-Suite at the Open
TORONTO, April 27, 2020 /CNW/ https://www.youtube.com/watch?v=i7qXYFwhH8g The C-Suite At the Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To […]
